Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7443 p297
17 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Further tensions emerge over royal college model

Chris Elmes

Bill Scott, Hemant Patel and Keith Ridge

Left to right: Bill Scott, Hemant Patel, the Society’s President and chairman of the meeting, and Keith Ridge

Further differences emerged last week over how membership of a royal-college-type body for the profession would be conferred or obtained. A range of opinions over how membership should be determined were first mooted shortly after publication of the White Paper (PJ, 2 March, p235).

At a briefing meeting, held at the Royal Pharmaceutical Society’s headquarters in London last week, representatives from the Society’s branch network and from various pharmacy organisations discussed the possible function and structure of a professional and clinical leadership body and how it might be sustained. The meeting was also attended by Keith Ridge and Bill Scott, the chief pharmaceutical officers for England and Scotland, members of the Society’s Council and the president of the Pharmaceutical Society of Northern Ireland.

Mark Walker, from the Oxfordshire branch of the Society, proposed that membership of a royal college should only be open to pharmacists. This would follow the medical royal colleges model, he said. “We have to make a decision over the next few weeks about inclusion or exclusion of pharmacy technicians. I feel they should be excluded,” he said. He added that the college could invite associate members once it has been created.

Tony Moffat, from the Academy of Pharmaceutical Sciences, argued that the college should be open to pharmaceutical scientists as well as pharmacists. There are many members of the APS who are not pharmacists, he said. “They join the Royal Pharmaceutical Society because they want to, not because they have to. There are a lot of people who work in the pharmaceutical sciences who would welcome joining a college that has a vision for the future for them,” he added. Dr Ridge agreed in principle, but said: “How we get there is up to you. It is about engagement and making that body something which that group of scientists and professionals would wish to join.”

In response to a question about student membership, John Gentle, a member of the Society’s Council, highlighted that there are already several models for students and preregistration trainees becoming associate members of a royal college.

Maria Christou, from the Norfolk and Norwich branch, argued that the royal college should be what people aspire to beyond basic registration. “It should not be about getting every member it can to join because they will pay a fee. Rather it should be around attracting people to join because what it is doing has a focus on postgraduate education and extended roles,” she said.

However, Mr Scott stressed that any royal college has to be cost-effective and therefore has to encourage all members of the Royal Pharmaceutical Society to join.

“I would see being on the registers — practising or non-practising — of the General Pharmaceutical Council as the first step to gaining membership [of the royal college],” he said. He added that faculties could be established to create opportunities for specialist pharmacists. “We would be failing if we did not have a structure which accommodates these excellent organisations within the college,” he said.

Most people saw the Society’s branch network as a valuable asset and believed it should support revalidation of pharmacists at a local level as part of any royal college.

Back to Top


©The Pharmaceutical Journal